TABLE 1.

AR-Ng testing in the CDC’s AR Lab Network^a

Network parameter	Value for the parameter
	2017	2018
Sites (no.)b
GISP	27	35
eGISP	12	9
SURRG	9	8
Participating clinics	63	63
N. gonorrhoeae isolate testing (no. of isolates)c
AST	8,214	8,628
Alert	531	646
Quick-send alert	47	55
WGS	605	3159

^aThe table summarizes information about sites and their associated laboratories participating in the AR Lab Network, as well as gonococcal isolates managed by the AR Lab Network.

^bProject funding cycles are August 1 to July 31 of the following year. The number of sites here refers to contribution status as of 31 August 2017 or 31 August 2018. All other numbers refer to calendar years 2017 and 2018. The number of reported sites can vary slightly between different publications, depending on whether sites funded by carryover funds are counted and whether sites submitting isolates without funding are included. GISP, Gonococcal Isolate Surveillance Project; eGISP, enhanced GISP; SURRG Strengthening the US. Response to Resistant Gonorrhea.

^cIsolate numbers are as reported by the regional laboratories and may vary slightly from final data reconciliation of each project. The number of alerts may slightly overrepresent a final, reconciled count since some isolates (<10) may be identified as an alert in both the cefixime and ceftriaxone categories. AST, antimicrobial susceptibility test; WGS, whole-genome sequencing.